Patrick Wood
Stock Analyst at UBS
(0.65)
# 4,224
Out of 5,040 analysts
441
Total ratings
49.5%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintained: Buy | $110 | $85.78 | +28.24% | 18 | Oct 8, 2026 | |
| ENOV Enovis | Reiterated: Buy | $51 → $44 | $17.61 | +149.86% | 2 | Oct 5, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $22 → $25 | $18.09 | +38.20% | 2 | Sep 15, 2026 | |
| COO The Cooper Companies | Rated: Hold | $75 → $66 | $54.75 | +20.55% | 16 | Sep 10, 2026 | |
| MDT Medtronic | Rated: Buy | $100 → $110 | $85.51 | +28.64% | 17 | Sep 3, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $25 → $28 | $19.11 | +46.52% | 2 | Sep 2, 2026 | |
| SOLV Solventum | Rated: Buy | $101 | $85.88 | +17.61% | 14 | Aug 20, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $190 → $205 | $180.16 | +13.79% | 17 | Aug 12, 2026 | |
| PODD Insulet | Rated: Hold | $150 | $134.36 | +11.64% | 17 | Aug 12, 2026 | |
| TFX Teleflex | Reiterated: Hold | $145 → $158 | $124.48 | +26.93% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $28 | $18.71 | +49.65% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $275 → $270 | $209.68 | +28.77% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $15.84 | +13.64% | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 → $6.3 | $4.80 | +31.25% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $8.47 | -5.55% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $88.49 | +35.61% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $16 | $10.25 | +56.10% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $17.91 | +11.67% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $80 → $77 | $81.07 | -5.02% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $19.10 | +30.89% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $23 | $17.34 | +32.64% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $67 | $41.58 | +61.14% | 21 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $172 | $172.18 | -0.10% | 10 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $137 → $125 | $98.73 | +26.61% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $25 | $23.97 | +4.30% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $96 | $84.30 | +13.88% | 16 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $100 → $82 | $73.75 | +11.19% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 → $19 | $13.00 | +46.15% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $39 | $67.45 | -42.18% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $650 → $500 | $414.52 | +20.62% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $13 → $20 | $22.36 | -10.55% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $445 → $400 | $275.40 | +45.24% | 7 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 66.64 | CHF 51.98 | +28.20% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $35.45 | +35.40% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $49.36 | -29.09% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $85 | $64.67 | +31.44% | 15 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $205 | $104.99 | +95.26% | 5 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 | $300.30 | -38.39% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $220 | $395.56 | -44.38% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $266 | $316.35 | -15.92% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $656 | $662.06 | -0.92% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $70.35 | n/a | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $15.35 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $258.11 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.32 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $0.07 | n/a | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $19.44 | n/a | 1 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $16 | $24.09 | n/a | 2 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,473p | 1,005p | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €35.31 → €45.00 | €21.40 | n/a | 2 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €64.58 → €42.00 | €42.46 | n/a | 2 | Dec 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 267.00 | CHF 569.00 | n/a | 1 | Jan 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $20.69 | n/a | 1 | Jul 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $176.78 | n/a | 2 | Dec 11, 2017 |
Edwards Lifesciences
Oct 8, 2026
Maintained: Buy
Price Target: $110
Current: $85.78
Upside: +28.24%
Enovis
Oct 5, 2026
Reiterated: Buy
Price Target: $51 → $44
Current: $17.61
Upside: +149.86%
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $18.09
Upside: +38.20%
The Cooper Companies
Sep 10, 2026
Rated: Hold
Price Target: $75 → $66
Current: $54.75
Upside: +20.55%
Medtronic
Sep 3, 2026
Rated: Buy
Price Target: $100 → $110
Current: $85.51
Upside: +28.64%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $19.11
Upside: +46.52%
Solventum
Aug 20, 2026
Rated: Buy
Price Target: $101
Current: $85.88
Upside: +17.61%
Becton, Dickinson and Company
Aug 12, 2026
Rated: Buy
Price Target: $190 → $205
Current: $180.16
Upside: +13.79%
Insulet
Aug 12, 2026
Rated: Hold
Price Target: $150
Current: $134.36
Upside: +11.64%
Teleflex
Aug 11, 2026
Reiterated: Hold
Price Target: $145 → $158
Current: $124.48
Upside: +26.93%
Aug 10, 2026
Rated: Buy
Price Target: $27 → $28
Current: $18.71
Upside: +49.65%
Aug 7, 2026
Rated: Buy
Price Target: $275 → $270
Current: $209.68
Upside: +28.77%
Aug 7, 2026
Reiterated: Hold
Price Target: $18
Current: $15.84
Upside: +13.64%
Aug 6, 2026
Reiterated: Hold
Price Target: $5.5 → $6.3
Current: $4.80
Upside: +31.25%
Aug 6, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $8.47
Upside: -5.55%
Aug 6, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $88.49
Upside: +35.61%
Aug 5, 2026
Rated: Buy
Price Target: $15 → $16
Current: $10.25
Upside: +56.10%
Aug 5, 2026
Reiterated: Hold
Price Target: $20
Current: $17.91
Upside: +11.67%
Aug 5, 2026
Rated: Hold
Price Target: $80 → $77
Current: $81.07
Upside: -5.02%
Aug 4, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $19.10
Upside: +30.89%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $21 → $23
Current: $17.34
Upside: +32.64%
Jul 30, 2026
Reiterated: Buy
Price Target: $118 → $67
Current: $41.58
Upside: +61.14%
Jul 30, 2026
Reiterated: Hold
Price Target: $72 → $172
Current: $172.18
Upside: -0.10%
Jul 28, 2026
Rated: Buy
Price Target: $137 → $125
Current: $98.73
Upside: +26.61%
Jul 28, 2026
Rated: Hold
Price Target: $15 → $25
Current: $23.97
Upside: +4.30%
Jul 28, 2026
Reiterated: Buy
Price Target: $75 → $96
Current: $84.30
Upside: +13.88%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $100 → $82
Current: $73.75
Upside: +11.19%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $10 → $19
Current: $13.00
Upside: +46.15%
Jul 28, 2026
Downgraded: Sell
Price Target: $39
Current: $67.45
Upside: -42.18%
Jul 28, 2026
Upgraded: Buy
Price Target: $650 → $500
Current: $414.52
Upside: +20.62%
Jul 28, 2026
Initiated Coverage: Sell
Price Target: $13 → $20
Current: $22.36
Upside: -10.55%
Jul 28, 2026
Upgraded: Buy
Price Target: $445 → $400
Current: $275.40
Upside: +45.24%
Mar 11, 2026
Reiterated: Hold
Price Target: CHF 66.64
Current: CHF 51.98
Upside: +28.20%
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $35.45
Upside: +35.40%
Feb 17, 2026
Reiterated: Hold
Price Target: $35
Current: $49.36
Upside: -29.09%
Feb 5, 2026
Reiterated: Hold
Price Target: $80 → $85
Current: $64.67
Upside: +31.44%
Dec 2, 2025
Reiterated: Buy
Price Target: $195 → $205
Current: $104.99
Upside: +95.26%
Nov 11, 2025
Reiterated: Hold
Price Target: $185
Current: $300.30
Upside: -38.39%
Nov 11, 2025
Reiterated: Buy
Price Target: $195 → $220
Current: $395.56
Upside: -44.38%
Nov 6, 2025
Reiterated: Hold
Price Target: $266
Current: $316.35
Upside: -15.92%
Oct 28, 2025
Reiterated: Buy
Price Target: $560 → $656
Current: $662.06
Upside: -0.92%
Aug 12, 2025
Reiterated: Buy
Price Target: $68
Current: $70.35
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: $12
Current: $15.35
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: $220
Current: $258.11
Upside: n/a
May 27, 2025
Reiterated: Hold
Price Target: $6
Current: $1.32
Upside: n/a
Jun 13, 2024
Reiterated: Hold
Price Target: $18
Current: $0.07
Upside: n/a
Aug 24, 2023
Downgraded: Hold
Price Target: $34
Current: $19.44
Upside: n/a
Oct 4, 2022
Reiterated: Hold
Price Target: $30 → $16
Current: $24.09
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: 1,473p
Current: 1,005p
Upside: n/a
Jul 28, 2021
Downgraded: Hold
Price Target: €35.31 → €45.00
Current: €21.40
Upside: n/a
Dec 3, 2020
Downgraded: Hold
Price Target: €64.58 → €42.00
Current: €42.46
Upside: n/a
Jan 31, 2019
Downgraded: Hold
Price Target: CHF 267.00
Current: CHF 569.00
Upside: n/a
Jul 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $20.69
Upside: n/a
Dec 11, 2017
Upgraded: Buy
Price Target: n/a
Current: $176.78
Upside: n/a